49 related articles for article (PubMed ID: 34894977)
1. Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.
Nayeem N; Yeasmin A; Cobos SN; Younes A; Hubbard K; Contel M
ChemMedChem; 2021 Nov; 16(21):3280-3292. PubMed ID: 34329530
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ERK signaling for treatment of ERRα positive TNBC.
Musheyev D; Miller E; Birnbaum N; Miller E; Erblich S; Schuck A; Alayev A
PLoS One; 2023; 18(5):e0283047. PubMed ID: 37163498
[TBL] [Abstract][Full Text] [Related]
3. Discovery of acetophenone/piperazin-2-one hybrids as selective anti-TNBC cancer agents by causing DNA damage.
Zhang ZJ; Liao YT; Wang W; Yang C; Li D; Shao LD
Bioorg Med Chem Lett; 2024 Aug; 108():129802. PubMed ID: 38777278
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer.
Long L; Xu J; Qi X; Pen Y; Wang C; Jiang W; Peng X; Hu Z; Yi W; Xie L; Lei X; Wang Z; Zhuo L
Eur J Med Chem; 2024 Jul; 273():116500. PubMed ID: 38776807
[TBL] [Abstract][Full Text] [Related]
5. Multipathway regulation induced by 4-(phenylsulfonyl)morpholine derivatives against triple-negative breast cancer.
Yang FW; Mai TL; Lin YJ; Chen YC; Kuo SC; Lin CM; Lee MH; Su JC
Arch Pharm (Weinheim); 2024 May; 357(5):e2300435. PubMed ID: 38314850
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Indole-Linked Thiadiazoles and their Anticancer Action against Triple-Negative Breast Cancer.
Gavadia R; Rasgania J; Sahu N; Nimesh S; Loveleen L; Mor S; Jakhar K
Chem Biodivers; 2024 Apr; 21(4):e202302000. PubMed ID: 38427723
[TBL] [Abstract][Full Text] [Related]
7. Novel Withanolides from
Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis.
Zhang W; Wang Y; Chen L; Chen H; Qi H; Zheng Y; Du Y; Zhang L; Wang T; Li Q
Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38072894
[TBL] [Abstract][Full Text] [Related]
9. PGC-1β and ERRα Promote Glutamine Metabolism and Colorectal Cancer Survival via Transcriptional Upregulation of PCK2.
Frodyma DE; Troia TC; Rao C; Svoboda RA; Berg JA; Shinde DD; Thomas VC; Lewis RE; Fisher KW
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230802
[TBL] [Abstract][Full Text] [Related]
10. Advances in Medicinal Chemistry of Estrogen-related Receptor Alpha (ERRα) Inverse Agonists.
Zhang H; Du Y; Zheng Y; Lv H; Yan Z; Dong N; Zhu Y; Shen J
Curr Top Med Chem; 2023; 23(20):1952-1963. PubMed ID: 37190810
[TBL] [Abstract][Full Text] [Related]
11. Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways.
Wu YM; Chen ZJ; Jiang GM; Zhang KS; Liu Q; Liang SW; Zhou Y; Huang HB; Du J; Wang HS
Oncotarget; 2016 Mar; 7(11):12568-81. PubMed ID: 26871469
[TBL] [Abstract][Full Text] [Related]
12. The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer
Gao Z; Wang T; Li R; Du Y; Lv H; Zhang L; Chen H; Shi X; Li Q; Shen J
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):125-134. PubMed ID: 34894977
[TBL] [Abstract][Full Text] [Related]
13. The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
Du Y; Song L; Zhang L; Ling H; Zhang Y; Chen H; Qi H; Shi X; Li Q
Eur J Med Chem; 2017 Aug; 136():457-467. PubMed ID: 28525844
[TBL] [Abstract][Full Text] [Related]
14. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
